News | March 10, 2014

Vucomp’s M-Vu Automatically Assesses Breast Density

March 10, 2014 — The need to assess breast density as part of routine mammography is well documented and is required by legislation in many states. Vucomp’s U.S. Food and Drug Administration (FDA)-cleared M-Vu Breast Density automatically assesses breast density, providing consistent and accurate measurements calibrated to a panel of 13 expert radiologists.

M-Vu Breast Density evaluates mammograms in much the same manner as experienced radiologists do: by analyzing the structure and texture of the tissue, rather than simply estimating total fibroglandular volume. This exclusive approach using appearance-based analysis provides useful adjunctive information. The resulting M-Vu Breast Density category is analogous to the BI-RADS density category, which reflects the degree to which the mammographic image exhibits a breast pattern that could camouflage cancer.

For physicians, this means fast and consistent assessments. For patients, it means peace of mind.

"We find M-Vu Breast Density very beneficial in providing consistent accurate breast density reads across our practice,” said Christine A. J. Granfield, M.D. Medical Director for Breast Imaging, Baptist Health. “While we already were providing the breast density estimate in the dictated report, it is reassuring to know we are now reporting this information accurately to the primary physician, which in turn can effect their patient management."

M-Vu Breast Density is compatible with mammography systems of Carestream, Fujifilm, GE, Giotto, Hologic, Konica Minolta, Philips, Planmed and Siemens. The tower or rack server communicates over Ethernet network. The product can be combined with the M-Vu CAD system for a comprehensive set of tools to help radiologists find breast cancer earlier, and Vucomp resources are ready and available to ensure an efficient installation.

For more information: www.vucomp.com

Related Content

In a demonstration on the exhibit floor of the SBI symposium, Koios software identified suspicious lesions in ultrasound images

In a demonstration on the exhibit floor of the SBI symposium, Koios software identified suspicious lesions in ultrasound images. Photo by Greg Freiherr

Feature | Artificial Intelligence | April 19, 2019 | By Greg Freiherr
Commercial efforts to develop...
Videos | Breast Imaging | April 18, 2019
In a keynote lecture at the Society of Breast Imaging (SBI)/American College of Radiology (ACR) 2019 Symposium, ...
Fatty tissue and breast density may be considered in the context of many factors that affect the occurrence and detection of breast cancer

Fatty tissue and breast density may be considered in the context of many factors that affect the occurrence and detection of breast cancer. Permission to publish provided by DenseBreast-info.org

Feature | Breast Imaging | April 18, 2019 | By Greg Freiherr
When planning a screening program to detect the early signs of breast cancer, age is a major consideration.
iCAD Appoints Stacey Stevens as President
News | Radiology Business | April 16, 2019
iCAD Inc. recently announced that Stacey Stevens has been named president. As president, Stevens will have expanded...
compressed breast during mammography.
360 Photos | 360 View Photos | April 16, 2019
A 360 view of a simulated breast compression for a...
A smart algorithm has been trained on a neural network to recognize the appearance of breast cancer in MR images

A smart algorithm has been trained on a neural network to recognize the appearance of breast cancer in MR images. The algorithm, described at the SBI/ACR Breast Imaging Symposium, used “Deep Learning,“ a form of machine learning, which is a type of artificial intelligence. Graphic courtesy of Sarah Eskreis-Winkler, M.D.

Feature | Artificial Intelligence | April 12, 2019 | By Greg Freiherr
The use of smart algorithms has the potential to make healthcare more efficient.
This image depicts ABUS images with QVCAD results

This image depicts ABUS images with QVCAD results.

Feature | Breast Imaging | April 12, 2019
Imaging Technology News spoke with Bob Foley, vice president of sales and marketing of QView Medical, Inc.,
Uterine Fibroid Embolization Safer and as Effective as Surgical Treatment
News | Interventional Radiology | April 05, 2019
Uterine fibroid embolization (UFE) effectively treats uterine fibroids with fewer post-procedure complications compared...